BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 1912980)

  • 1. Blockade of intracellular actions of calcium may protect against ischaemic damage to the gerbil brain.
    Asano T; Ikegaki I; Satoh S; Mochizuki D; Hidaka H; Suzuki Y; Shibuya M; Sugita K
    Br J Pharmacol; 1991 Aug; 103(4):1935-8. PubMed ID: 1912980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotective properties of a protein kinase inhibitor against ischaemia-induced neuronal damage in rats and gerbils.
    Satoh S; Ikegaki I; Suzuki Y; Asano T; Shibuya M; Hidaka H
    Br J Pharmacol; 1996 Aug; 118(7):1592-6. PubMed ID: 8842419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative protective effects of nicardipine, flunarizine, lidoflazine and nimodipine against ischaemic injury in the hippocampus of the Mongolian gerbil.
    Alps BJ; Calder C; Hass WK; Wilson AD
    Br J Pharmacol; 1988 Apr; 93(4):877-83. PubMed ID: 3390655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of action of a novel antivasospasm drug, HA1077.
    Asano T; Ikegaki I; Satoh S; Suzuki Y; Shibuya M; Takayasu M; Hidaka H
    J Pharmacol Exp Ther; 1987 Jun; 241(3):1033-40. PubMed ID: 3598899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasodilator actions of HA1077 in vitro and in vivo putatively mediated by the inhibition of protein kinase.
    Asano T; Suzuki T; Tsuchiya M; Satoh S; Ikegaki I; Shibuya M; Suzuki Y; Hidaka H
    Br J Pharmacol; 1989 Dec; 98(4):1091-100. PubMed ID: 2611484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of HA1077, a novel calciumantagonistic spasmolytic agent on intracerebral arterioles of rats.
    Takayasu M; Dacey RG
    Acta Neurochir (Wien); 1990; 103(1-2):67-70. PubMed ID: 2360470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Protective effect of nicardipine hydrochloride on the evolution of delayed neuronal death--an immunohistochemical study].
    Tomimoto H; Wakita H; Akiguchi I; Kimura J
    No To Shinkei; 1994 Mar; 46(3):251-6. PubMed ID: 8192940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of HA compound calcium antagonists on delayed cerebral vasospasm in dogs.
    Takayasu M; Suzuki Y; Shibuya M; Asano T; Kanamori M; Okada T; Kageyama N; Hidaka H
    J Neurosurg; 1986 Jul; 65(1):80-5. PubMed ID: 3712031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitric oxide: a downstream mediator of calcium toxicity in the ischemic cascade.
    Maiese K; Wagner J; Boccone L
    Neurosci Lett; 1994 Jan; 166(1):43-7. PubMed ID: 8190356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of HA1077, an intracellular calcium antagonist, on neurotransmitter metabolism in rat brain in vivo.
    Kondoh Y; Mizusawa S; Murakami M; Nagata K; Nakamichi H; Watanabe K
    Metab Brain Dis; 1991 Sep; 6(3):111-24. PubMed ID: 1779923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelin: a potential modulator of cerebral vasospasm.
    Asano T; Ikegaki I; Satoh S; Suzuki Y; Shibuya M; Sugita K; Hidaka H
    Eur J Pharmacol; 1990 Nov; 190(3):365-72. PubMed ID: 2272374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fasudil (HA1077), an intracellular calcium antagonist, improves neurological deficits and tissue potassium loss in focal cerebral ischemia in gerbils.
    Kondoh Y; Mizusawa S; Murakami M; Nakamichi H; Nagata K
    Neurol Res; 1997 Apr; 19(2):211-5. PubMed ID: 9175152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible prophylactic potential of HA1077, a Ca2+ channel antagonist and vasodilator, on chronic cerebral vasospasm.
    Satoh S; Suzuki Y; Harada T; Ikegaki I; Asano T; Shibuya M; Sugita K; Hidaka H
    Eur J Pharmacol; 1992 Sep; 220(2-3):243-8. PubMed ID: 1425995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tetrandrine vs nicardipine in cerebral ischemia-reperfusion damages in gerbils.
    Sun F; Liu TP
    Zhongguo Yao Li Xue Bao; 1995 Mar; 16(2):145-8. PubMed ID: 7597916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of HA1077, a novel protein kinase inhibitor, on reductions of cerebral blood flow and glucose metabolism following acute and/or chronic bilateral carotid artery ligation in Wistar rats.
    Tsuchiya M; Sako K; Yonemasu Y; Asano T
    Exp Brain Res; 1993; 97(2):233-8. PubMed ID: 8150043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HA1077, a novel calcium antagonistic antivasospasm drug, increases both cerebral blood flow and glucose metabolism in conscious rats.
    Sako K; Tsuchiya M; Yonemasu Y; Asano T
    Eur J Pharmacol; 1991 Dec; 209(1-2):39-43. PubMed ID: 1814759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations of calcium/calmodulin-dependent protein kinase II activity in ischaemia-induced neuronal death and neuronal protection against ischaemia in the gerbil hippocampus.
    Uno H; Kobayashi H; Handa Y; Kabuto M; Kubota T
    Acta Neurochir (Wien); 1999; 141(3):287-94. PubMed ID: 10214486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of calcium channel blockers on cerebral ischemia-induced hyperactivity in Mongolian gerbils.
    Araki H; Hino N; Karasawa Y; Kawasaki H; Gomita Y
    Physiol Behav; 1999 Oct; 67(4):573-7. PubMed ID: 10549896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effects of a novel calcium antagonist with platelet-activating factor-antagonistic action, F-0401, against ischemic brain damage.
    Chen T; Kato H; Ban H; Nakata N; Liu XH; Itoyama Y; Kogure K
    Arch Int Pharmacodyn Ther; 1994; 327(3):266-78. PubMed ID: 7848011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the intracellular calcium antagonist HA1004 on cerebral blood flow in rats.
    Okada T; Shibuya M; Suzuki Y; Ikegaki I; Kageyama N; Asano T; Hidaka H
    Neurol Med Chir (Tokyo); 1988 Jul; 28(7):625-30. PubMed ID: 2462166
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.